Client’s Testimonial:
“Thank you guys very much for helping me get the I-140 approved.”
On February 1st, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: February 1st, 2016
Processing Time: 5 months, 11 days (Premium Processing requested)
Case Summary:
“Chronic pain afflicts millions of Americans and available therapies are woefully inadequate […] The work of [Client’s] is an important contribution toward the goal of finding therapies with greater efficacy and with reduced, or no risk, of addiction.”
The quote is excerpted from a testimonial contributed by an expert in the field of pharmacology. Our client, a postdoctoral research fellow from China, obtained this letter and several others to strengthen her EB-1A (Alien of Extraordinary Ability) petition dossier. Besides these letters of support, North America Immigration Law Group also included demonstrations of our client’s influence in her field. We documented 171 citations to her 21 published papers and included examples of the 12 reviews that she completed for more than half a dozen scientific journals. Most importantly, we described our client’s research efforts on the causes of chronic pain and how to treat it. We proved that her work improves the lifetime of key diabetes 2 medications, determines the mechanisms that lead to morphine analgesic tolerance and pain hypersensitivity states, and outlines the changes that the nervous system goes through after nerve injuries. Our EB-1A petition dossier firmly established the value of our client’s findings to the medical and scientific areas in the United States.
At our client’s request, our firm upgraded her I-140 to be adjudicated under Premium Processing almost five months after we filed her case. The USCIS granted their approval two weeks later. As our client chose to file her I-485 (final step in the green card process) while her I-140 was pending, she is currently awaiting her second approval notice. We wish her the best in obtaining her permanent residency.
We are pleased to announce that North America Immigration Law Group has so far received over 3,500 EB-1A, EB-1B and EB-2 NIW approval notices. In 2014 and 2015, the approval rate is 98.22% for cases using our "Approval or Refund®" (money back guarantee) service and 96.95% for all kinds of services.
For NIW cases, the approval rate is 99.18% for cases using our "Approval or Refund®" (money back guarantee) service and the overall approval rate for all NIW cases is 98.47%.
For EB1A cases, the approval rate is 97.25% for "Approval or Refund®" (money back guarantee) service and the overall approval rate for all EB1A cases is 95.27%.
We are one of the leading U.S. immigration law firms providing the most comprehensive services for EB-1/NIW petition with a large volume of approval cases and high approval rate.
Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A, EB1B, and NIW petitions.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: http://www.wegreened.com/eb1_niw_approvals
Success Stories: http://blog.wegreened.com/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.